id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-R01-SFUND-2026-0826-0001,EPA,EPA-R01-SFUND-2026-0826,DRAFT THIRD EXPLANATION OF SIGNIFICANT DIFFERENCES (ESD) - OPERABLE UNIT (OU) 1 FOR PUBLIC COMMENT,Notice,,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,2026-05-31T03:59:59Z,2026-05-15T17:14:22Z,,1,0,09000064b92d8fff
EPA_FRDOC_0001-32815,EPA,EPA_FRDOC_0001,"Environmental Impact Statements; Availability, etc.",Notice,,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T16:06:05Z,2026-09788,0,0,09000064b92da963
FDA-2025-N-0421-0002,FDA,FDA-2025-N-0421,Oscar Bobo: Final Debarment Order,Notice,Statutory Debarment,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T17:48:54Z,2026-09767,1,0,09000064b92da9bd
FWS-HQ-IA-2026-1915-0001,FWS,FWS-HQ-IA-2026-1915,Agency Information Collection Activities; Submission to the Office of Management and Budget; Federal Fish and Wildlife Permit Applications and Reports-Management Authority,Notice,,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T16:50:38Z,2026-09805,0,0,09000064b92da383
FWS-R5-FAC-2026-1684-0001,FWS,FWS-R5-FAC-2026-1684,Agency Information Collection Activities; Submission to the Office of Management and Budget; Horseshoe Crab and Cooperative Fish Tagging Programs,Notice,,2026-05-15T04:00:00Z,2026,5,,,2026-05-15T16:47:48Z,2026-09751,0,0,09000064b92da381
FWS-HQ-IA-2026-0298-0001,FWS,FWS-HQ-IA-2026-0298,Foreign Endangered Species; Receipt of Permit Applications,Notice,,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,2026-06-16T03:59:59Z,2026-05-15T16:53:53Z,2026-09807,1,0,09000064b92db145
APHIS-2026-0101-0001,APHIS,APHIS-2026-0101,Requests for Nominations: General Conference Committee of the National Poultry Improvement Plan,Notice,Notice of Conference,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T16:55:24Z,2026-09695,0,0,09000064b92d8242
APHIS-2026-0496-0001,APHIS,APHIS-2026-0496,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Restrictions on Importation of Live Poultry, Poultry Meat, and Other Poultry Products from Specified Regions",Notice,Information Collection Request (ICR),2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,2026-07-14T03:59:59Z,2026-05-14T17:02:55Z,2026-09639,1,0,09000064b92d74a2
EPA-R09-OAR-2025-0454-0026,EPA,EPA-R09-OAR-2025-0454,"Permits; Applications, Issuances, etc.: Jamul Casino Resort, Clean Air Act Tribal Minor New Source Review",Notice,,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T21:56:52Z,2026-09588,0,0,09000064b92d4a5b
EPA_FRDOC_0001-32804,EPA,EPA_FRDOC_0001,Draft Fiscal Year 2027 Evidence Plan,Notice,,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,2026-05-29T03:59:59Z,2026-05-14T16:25:42Z,2026-09586,1,0,09000064b92d74d0
EPA_FRDOC_0001-32807,EPA,EPA_FRDOC_0001,"Proposed Settlement Agreement, Stipulation, Order, and Judgment, etc.: CERCLA; Cost Recovery for the Desha Road Superfund Site, Tappahannock, Essex County, VA",Notice,,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,2026-06-16T03:59:59Z,2026-05-14T16:26:15Z,2026-09587,1,0,09000064b92d8203
EPA_FRDOC_0001-32810,EPA,EPA_FRDOC_0001,"Hearings, Meetings, Proceedings, etc.: Ozone Transport Commission and the Mid-Atlantic Northeast Visibility Union",Notice,,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T16:26:22Z,2026-09585,0,0,09000064b92d8248
USDA_FRDOC_0001-3306,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T16:26:14Z,2026-09645,0,0,09000064b92d8201
APHIS-2026-0431-0001,APHIS,APHIS-2026-0431,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Federally Recognized State Managed Phytosanitary Program",Notice,Information Collection Request (ICR),2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,2026-07-14T03:59:59Z,2026-05-13T17:08:42Z,2026-09519,1,0,09000064b92d4a1a
FDA-2026-N-4126-0001,FDA,FDA-2026-N-4126,Azodicarbonamide (ADA); Request for Information,Notice,Requests for Information (RFI),2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,2026-07-14T03:59:59Z,2026-05-13T17:13:38Z,2026-09508,1,0,09000064b92d17fd
FDA-2026-N-3098-0001,FDA,FDA-2026-N-3098,Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting,Notice,60 Day Proposed Information Collection,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,2026-07-14T03:59:59Z,2026-05-13T16:56:28Z,2026-09543,1,0,09000064b92d4966
FDA-2026-N-2526-0001,FDA,FDA-2026-N-2526,Butylated Hydroxytoluene (BHT); Request for Information,Notice,Requests for Information (RFI),2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,2026-07-14T03:59:59Z,2026-05-13T17:01:00Z,2026-09507,1,0,09000064b92d4931
FDA-2019-N-0994-0230,FDA,FDA-2019-N-0994,"Modified Risk Tobacco Product Application: Renewal Applications for
VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.",Notice,Request for Comments,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-15T09:00:24Z,2026-09544,1,0,09000064b92d47df
FDA-2025-N-1600-0003,FDA,FDA-2025-N-1600,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3,Notice,30 Day Proposed Information Collection,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,2026-06-13T03:59:59Z,2026-05-13T17:17:21Z,2026-09448,1,0,09000064b92d4828
FDA-2026-N-0005-0001,FDA,FDA-2026-N-0005,Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information,Notice,Requests for Information (RFI),2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,2026-07-14T03:59:59Z,2026-05-13T17:06:21Z,2026-09533,1,0,09000064b92d48f3
EPA-HQ-OPPT-2003-0004-0151,EPA,EPA-HQ-OPPT-2003-0004,Access to Confidential Business Information: Science Applications International Corp.,Notice,,2026-05-12T04:00:00Z,2026,5,,,2026-05-12T18:23:59Z,2026-09370,0,0,09000064b92d164d
FDA-2026-N-4492-0001,FDA,FDA-2026-N-4492,Drug Repurposing for Unmet Medical Needs; Request for Information,Notice,Requests for Information (RFI),2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,2026-06-12T03:59:59Z,2026-05-15T09:00:24Z,2026-09366,1,0,09000064b92d15f4
FDA-2017-N-5925-0040,FDA,FDA-2017-N-5925,21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria web page,Notice,Request for Comments,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T22:58:36Z,2026-09438,1,0,09000064b92d17af
FDA-2026-D-5083-0001,FDA,FDA-2026-D-5083,Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization; Guidance for Industry; Availability,Notice,Notice of Availability,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T17:17:05Z,2026-09368,0,0,09000064b92d1762
FDA-2025-N-2220-0002,FDA,FDA-2025-N-2220,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products,Notice,30 Day Proposed Information Collection,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,2026-06-11T03:59:59Z,2026-05-11T21:25:31Z,2026-09244,1,0,09000064b92cfa18
FDA-2011-N-0655-0042,FDA,FDA-2011-N-0655,"Animal Generic Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Generic Drug User Fee Act Reauthorization; Request for
Notification of Stakeholder Intent To Participate",Notice,Notice of Intent,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T21:26:21Z,2026-09284,0,0,09000064b92cf91b
FDA-2026-N-4573-0001,FDA,FDA-2026-N-4573,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; AVLAYAH (tividenofusp alfa-eknm),Notice,Announcement,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T17:34:15Z,2026-09242,0,0,09000064b92cf987
FDA-2013-D-1319-0015,FDA,FDA-2013-D-1319,Pulmonary Tuberculosis: Developing Drugs for Treatment; Guidance for Industry; Availability,Notice,Notice of Availability,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T17:27:37Z,2026-09269,0,0,09000064b92cf98a
FDA-2018-D-4693-0022,FDA,FDA-2018-D-4693,Postapproval Pregnancy Safety Studies; Guidance for Industry; Availability,Notice,Notice of Availability,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T17:36:17Z,2026-09268,0,0,09000064b92cf982
FDA-2011-N-0656-1315,FDA,FDA-2011-N-0656,"Animal Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Drug User Fee Act Reauthorization; Request for Notification of Stakeholder
Intent To Participate",Notice,General Notice,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T17:56:32Z,2026-09283,0,0,09000064b92cacd0
FDA-2022-D-1261-0003,FDA,FDA-2022-D-1261,"Clostridioides Difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, or Prevention; Guidance for Industry; Availability",Notice,Notice of Availability,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T17:42:11Z,2026-09267,0,0,09000064b92cf922
FWS-HQ-IA-2026-0760-0001,FWS,FWS-HQ-IA-2026-0760,Foreign Endangered Species; Receipt of Permit Applications,Notice,,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,2026-06-11T03:59:59Z,2026-05-11T17:39:40Z,2026-09233,1,0,09000064b92cf3d8
FWS-HQ-IA-2026-1057-0001,FWS,FWS-HQ-IA-2026-1057,Foreign Endangered Species; Receipt of Permit Applications,Notice,,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,2026-06-11T03:59:59Z,2026-05-13T09:00:30Z,2026-09234,1,0,09000064b92cf3d5
EPA_FRDOC_0001-32797,EPA,EPA_FRDOC_0001,"Environmental Impact Statements; Availability, etc.",Notice,,2026-05-08T04:00:00Z,2026,5,2026-05-08T04:00:00Z,,2026-05-08T16:25:27Z,2026-09180,0,0,09000064b92c962b
FDA-2026-P-0749-0004,FDA,FDA-2026-P-0749,"Determination That Leucovorin Calcium, Oral Solution, Equivalent to 60 Milligrams Base/Vial, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2026-05-08T04:00:00Z,2026,5,,,2026-05-08T17:04:13Z,2026-09199,0,0,09000064b92c97d0
EPA-R03-OW-2025-2004-0006,EPA,EPA-R03-OW-2025-2004,Final Affirmative Determination: Virginia; Waters of the Northern Neck Peninsula Vessel Sewage No-Discharge Zone,Notice,,2026-05-07T04:00:00Z,2026,5,2026-05-07T04:00:00Z,,2026-05-07T17:34:41Z,2026-09042,0,0,09000064b92c865f
EPA_FRDOC_0001-32793,EPA,EPA_FRDOC_0001,"Clean Air Act Operating Permit Program: Order on Petitions for Objection to State Operating Permits for Bargath, LLC's Clough, Heath, Hyrup, Jangles and Starkey Gulch Compressor Stations, and Grand River Gathering, LLC's East Mamm Creek Compressor Station",Notice,,2026-05-07T04:00:00Z,2026,5,2026-05-07T04:00:00Z,,2026-05-07T16:26:20Z,2026-09053,0,0,09000064b92c861b
EPA-R01-SFUND-2025-3126-0001,EPA,EPA-R01-SFUND-2025-3126,DRAFT THIRD EXPLANATION OF SIGNIFICANT DIFFERENCES (ESD) - OPERABLE UNIT (OU) 3 FOR PUBLIC COMMENT,Notice,,2026-05-07T04:00:00Z,2026,5,2026-05-07T04:00:00Z,2026-05-19T03:59:59Z,2026-05-07T22:10:10Z,,1,0,09000064b9284542
FDA-2025-P-7054-0006,FDA,FDA-2025-P-7054,"Determination That MICARDIS (Telmisartan), Tablets, 20 Milligrams and 80 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2026-05-07T04:00:00Z,2026,5,2026-05-07T04:00:00Z,,2026-05-07T17:15:35Z,2026-09011,0,0,09000064b92c66bf
FDA-2023-D-2370-0007,FDA,FDA-2023-D-2370,Patient-Matched Guides for Orthopedic Implants; Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2026-05-07T04:00:00Z,2026,5,2026-05-07T04:00:00Z,,2026-05-07T17:05:32Z,2026-09023,0,0,09000064b92c78fc
FDA-2026-N-4291-0001,FDA,FDA-2026-N-4291,"Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications",Notice,Withdrawal,2026-05-07T04:00:00Z,2026,5,2026-05-07T04:00:00Z,,2026-05-07T16:54:25Z,2026-09012,0,0,09000064b92c85aa
FDA-2026-N-0008-0004,FDA,FDA-2026-N-0008,Advisory Committee; Blood Products Advisory Committee; Renewal,Notice,Notice of Renewal,2026-05-07T04:00:00Z,2026,5,2026-05-07T04:00:00Z,,2026-05-07T17:02:15Z,2026-09108,0,0,09000064b92c85a3
FWS-R4-ES-2026-0727-0001,FWS,FWS-R4-ES-2026-0727,"Receipt of Incidental Take Permit Application and Proposed Habitat Conservation Plan for Sand Skink and Blue-tailed Mole Skink; Polk County, FL; Categorical Exclusion (applicant: FLLWCC, LLC / FLOW CC, LLC)",Notice,,2026-05-07T04:00:00Z,2026,5,2026-05-07T04:00:00Z,2026-06-09T03:59:59Z,2026-05-07T15:32:32Z,2026-09093,1,0,09000064b92c7747
EPA-HQ-OPP-2025-3951-0001,EPA,EPA-HQ-OPP-2025-3951,"Permits; Applications, Issuances, etc.: Pesticide Experimental Use",Notice,,2026-05-06T04:00:00Z,2026,5,2026-05-06T04:00:00Z,2026-06-06T03:59:59Z,2026-05-16T12:32:23Z,2026-08808,1,0,09000064b92c5b51
FDA-2026-N-4588-0001,FDA,FDA-2026-N-4588,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; OTARMENI (lunsotogene parvec-cwha),Notice,Announcement,2026-05-06T04:00:00Z,2026,5,2026-05-06T04:00:00Z,,2026-05-06T17:40:41Z,2026-08913,0,0,09000064b92c5bca
FDA-2026-P-1306-0004,FDA,FDA-2026-P-1306,"Determination That DEXAMETHASONE (Dexamethasone) Elixir, 0.5 Milligrams/5 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2026-05-06T04:00:00Z,2026,5,2026-05-06T04:00:00Z,,2026-05-06T17:34:01Z,2026-08939,0,0,09000064b92c65a4
FWS-R1-ES-2026-0959-0001,FWS,FWS-R1-ES-2026-0959,"Endangered and Threatened Wildlife and Plants; Initiation of 5-Year Status Reviews for 78 Species in Hawaii, Idaho, Oregon, and California",Notice,,2026-05-06T04:00:00Z,2026,5,2026-05-06T04:00:00Z,2026-07-07T03:59:59Z,2026-05-06T15:38:11Z,2026-08969,1,0,09000064b92c565c
EPA-HQ-OPPT-2018-0427-0182,EPA,EPA-HQ-OPPT-2018-0427,"1,2-Dichloroethane; Final Risk Evaluation Under the Toxic Substances Control Act (TSCA); Notice of Availability",Notice,Notice of Data Availability,2026-05-05T04:00:00Z,2026,5,,,2026-05-05T17:24:29Z,2026-08682,0,0,09000064b92c373d
EPA-HQ-OW-2002-0059-0029,EPA,EPA-HQ-OW-2002-0059,"Proposed Information Collection Request; Clean Water State Revolving Fund and Drinking Water State Revolving Fund Programs; EPA ICR No. 1803.10, OMB Control No. 2040-0185",Notice,Information Collection Request (ICR),2026-05-05T04:00:00Z,2026,5,2026-05-05T04:00:00Z,2026-07-07T03:59:59Z,2026-05-06T20:13:53Z,2026-08693,1,0,09000064b92c12bb
FWS-HQ-FAC-2026-1123-0001,FWS,FWS-HQ-FAC-2026-1123,Sport Fishing and Boating Partnership Council; Call for Nominations,Notice,,2026-05-05T04:00:00Z,2026,5,,,2026-05-05T18:08:52Z,2026-08734,0,0,09000064b92c2665
FDA-2026-N-3070-0001,FDA,FDA-2026-N-3070,Agency Information Collection Activities; Proposed Collection; Comment Request; National Youth Tobacco Survey,Notice,60 Day Proposed Information Collection,2026-05-04T04:00:00Z,2026,5,2026-05-04T04:00:00Z,2026-07-07T03:59:59Z,2026-05-04T19:19:25Z,2026-08604,1,0,09000064b92c115c
FWS-R8-ES-2025-0054-0001,FWS,FWS-R8-ES-2025-0054,"Incidental Take Permit Application for the Desert Tortoise; Draft Habitat Conservation Plan and Draft Environmental Assessment; CalPortland—Oro Grande Quarries and Cement Plant, San Bernardino County, CA",Notice,,2026-05-04T04:00:00Z,2026,5,2026-05-04T04:00:00Z,2026-06-04T03:59:59Z,2026-05-05T20:22:50Z,2026-08579,1,0,09000064b92c12c3
FWS-R3-ES-2026-0860-0001,FWS,FWS-R3-ES-2026-0860,"Endangered and Threatened Species; Receipt of Recovery Permit Applications (applicant: Missouri Department of Conservation, Warsaw, MO)",Notice,,2026-05-04T04:00:00Z,2026,5,2026-05-04T04:00:00Z,2026-06-04T03:59:59Z,2026-05-05T20:23:13Z,2026-08574,1,0,09000064b92be1b3
FWS-HQ-IA-2025-1441-0001,FWS,FWS-HQ-IA-2025-1441,"Endangered Species; Issuance of Permits (applicant: Coastal Exotics, Inc.)",Notice,,2026-05-04T04:00:00Z,2026,5,,,2026-05-04T18:55:56Z,2026-08592,0,0,09000064b92c04f0
EPA_FRDOC_0001-32784,EPA,EPA_FRDOC_0001,"Environmental Impact Statements; Availability, etc.",Notice,,2026-05-01T04:00:00Z,2026,5,2026-05-01T04:00:00Z,,2026-05-01T16:25:15Z,2026-08520,0,0,09000064b92bb772
FDA-2018-N-3240-0377,FDA,FDA-2018-N-3240,"List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act",Notice,Request for Comments,2026-05-01T04:00:00Z,2026,5,2026-05-01T04:00:00Z,2026-07-01T03:59:59Z,2026-05-16T09:00:17Z,2026-08552,1,0,09000064b92bb724
FDA-2026-N-3499-0001,FDA,FDA-2026-N-3499,Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments,Notice,Request for Comments,2026-05-01T04:00:00Z,2026,5,2026-05-01T04:00:00Z,2026-07-01T03:59:59Z,2026-05-02T09:00:17Z,2026-08521,1,0,09000064b92bb7fb
FDA-2026-N-3947-0001,FDA,FDA-2026-N-3947,Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comments,Notice,Request for Comments,2026-05-01T04:00:00Z,2026,5,2026-05-01T04:00:00Z,2026-07-01T03:59:59Z,2026-05-09T09:00:22Z,2026-08524,1,0,09000064b92bb6d7
FDA-2026-N-4268-0001,FDA,FDA-2026-N-4268,Medical Devices; Exemptions From Premarket Notification: Certain Class II Devices; Request for Comments,Notice,Request for Comments,2026-05-01T04:00:00Z,2026,5,2026-05-01T04:00:00Z,2026-07-01T03:59:59Z,2026-05-09T09:00:22Z,2026-08499,1,0,09000064b92bb7b3
USDA_FRDOC_0001-3302,USDA,USDA_FRDOC_0001,Rescission of Final Determination: Adoption of Energy Efficiency Standards for New Construction of Department of Housing and Urban Development and Department of Agriculture Financed Housing,Notice,,2026-05-01T04:00:00Z,2026,5,2026-05-01T04:00:00Z,,2026-05-01T16:25:16Z,2026-08531,0,0,09000064b92bb7f9
APHIS-2026-0331-0001,APHIS,APHIS-2026-0331,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Pale Cyst Nematode",Notice,Information Collection Request (ICR),2026-04-30T04:00:00Z,2026,4,2026-04-30T04:00:00Z,2026-06-30T03:59:59Z,2026-04-30T19:42:56Z,2026-08418,1,0,09000064b92b8095
EPA_FRDOC_0001-32781,EPA,EPA_FRDOC_0001,Draft Fiscal Year 2027 Evidence Plan,Notice,,2026-04-30T04:00:00Z,2026,4,2026-04-30T04:00:00Z,,2026-04-30T20:46:24Z,2026-08379,0,0,09000064b92b7f65
EPA_FRDOC_0001-32782,EPA,EPA_FRDOC_0001,"Proposed Settlement Agreement, Stipulation, Order, and Judgment, etc.: CERCLA; Goodrich Asbestos Superfund Site in Ottawa County, Miami, OK",Notice,,2026-04-30T04:00:00Z,2026,4,,,2026-04-30T23:32:03Z,2026-08370,0,0,09000064b92b7f66
FDA-2026-P-0655-0003,FDA,FDA-2026-P-0655,"Determination FENOGLIDE (Fenofibrate) Tablets, 40 Milligrams and 120 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2026-04-30T04:00:00Z,2026,4,,,2026-04-30T17:56:39Z,2026-08390,0,0,09000064b92b7f6c
FDA-2026-N-0499-0002,FDA,FDA-2026-N-0499,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice,Notice,30 Day Proposed Information Collection,2026-04-30T04:00:00Z,2026,4,2026-04-30T04:00:00Z,2026-06-02T03:59:59Z,2026-04-30T17:46:42Z,2026-08417,1,0,09000064b92b80f2
FDA-2026-N-0008-0003,FDA,FDA-2026-N-0008,Advisory Committee; Pharmacy Compounding Advisory Committee; Renewal,Notice,Notice of Renewal,2026-04-30T04:00:00Z,2026,4,,,2026-04-30T18:03:08Z,2026-08378,0,0,09000064b92b7f20
FDA-2025-P-3849-0004,FDA,FDA-2025-P-3849,"Determination That OZEMPIC (Semaglutide) Solution, 2 Milligrams Per 1.5 Milliliters Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2026-04-30T04:00:00Z,2026,4,,,2026-04-30T18:12:42Z,2026-08435,0,0,09000064b92b5df8
FDA-2026-N-3532-0001,FDA,FDA-2026-N-3532,Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies,Notice,60 Day Proposed Information Collection,2026-04-30T04:00:00Z,2026,4,2026-04-30T04:00:00Z,2026-06-30T03:59:59Z,2026-05-02T09:00:17Z,2026-08371,1,0,09000064b92b7fb3
FDA-2026-N-1321-0001,FDA,FDA-2026-N-1321,"ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing",Notice,Withdrawal,2026-04-30T04:00:00Z,2026,4,2026-04-30T04:00:00Z,2026-06-30T03:59:59Z,2026-05-16T09:00:16Z,2026-08455,1,0,09000064b92b7e81
USDA_FRDOC_0001-3301,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2026-04-30T04:00:00Z,2026,4,2026-04-30T04:00:00Z,,2026-04-30T16:25:46Z,2026-08395,0,0,09000064b92b7f69
EPA-HQ-OPPT-2026-1849-0004,EPA,EPA-HQ-OPPT-2026-1849,Certain New Chemicals or Significant New Uses: Statements of Findings - February 2026,Notice,,2026-04-29T04:00:00Z,2026,4,,,2026-04-29T17:11:49Z,2026-08340,0,0,09000064b92b5d06
FDA-2026-N-4390-0001,FDA,FDA-2026-N-4390,AI-Enabled Optimization of Early- Phase Clinical Trials Pilot Program; Request for Information,Notice,Requests for Information (RFI),2026-04-29T04:00:00Z,2026,4,2026-04-29T04:00:00Z,2026-05-30T03:59:59Z,2026-05-16T12:32:04Z,2026-08281,1,0,09000064b92b54c8
EPA-HQ-OLEM-2020-0527-0174,EPA,EPA-HQ-OLEM-2020-0527,Interim PFAS Destruction and Disposal Guidance; Notice of Availability for Public Comment,Notice,Notice of Data Availability,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,2026-06-30T03:59:59Z,2026-05-14T09:00:29Z,2026-08174,1,0,09000064b92b2330
FDA-2026-N-1832-0014,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1303 - Bifidobacterium animalis subsp. lactis CGMCC5470,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:29:48Z,,0,0,09000064b92a8cd6
FDA-2025-N-1928-0067,FDA,FDA-2025-N-1928,GRAS Notice (GRN) 1279 – Saccharomyces cerevisiae CCTCC M2025194 – amendments,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:24:49Z,,0,0,09000064b92a80fa
FDA-2026-N-1832-0008,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1297 - Enzyme-hydrolyzed brown rice protein - Part 3 of 3,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:28:45Z,,0,0,09000064b92a8ccc
FDA-2025-N-1928-0066,FDA,FDA-2025-N-1928,GRAS Notice (GRN) 1278 – Lactiplantibacillus plantarum CGMCC 6312 – amendments,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:24:47Z,,0,0,09000064b92a80f9
FDA-2025-N-1928-0064,FDA,FDA-2025-N-1928,GRAS Notice (GRN) 1256 – Lemna leaf protein – amendments,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:18:46Z,,0,0,09000064b92a80f7
FDA-2026-N-1832-0007,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1297 - Enzyme-hydrolyzed brown rice protein - Part 2 of 3,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:28:26Z,,0,0,09000064b92a8ccb
FDA-2025-N-1928-0065,FDA,FDA-2025-N-1928,GRAS Notice (GRN) 1276 – Cellulase enzyme preparation produced by Trichoderma reesei expressing a gene encoding a cellulase from Aspergillus niger – amendments,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:24:37Z,,0,0,09000064b92a80f8
FDA-2026-N-1832-0015,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1304 - Preparation containing at least three bacteriophages (phage) specific to Listeria spp.,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:29:52Z,,0,0,09000064b92a8cd7
FDA-2026-N-1832-0003,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1293 - Brazzein preparation produced by Komagataella phaffii “RA-b” expressing a gene encoding for brazzein from Pentadiplandra brazzeana - Part 2 of 2,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:27:02Z,,0,0,09000064b92a8cc6
FDA-2026-N-1832-0005,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1295 - Brazzein preparation produced by Komagataella phaffii GS115 expressing a gene encoding for brazzein from Pentadiplandra brazzeana,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:27:45Z,,0,0,09000064b92a8cc9
FDA-2025-N-1928-0069,FDA,FDA-2025-N-1928,GRAS Notice (GRN) 1296 - Erythritol produced through fermentation of glucose by Yarrowia lipolytica,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:25:01Z,,0,0,09000064b92a80fc
FDA-2025-N-1928-0068,FDA,FDA-2025-N-1928,GRAS Notice (GRN) 1292 - Citrus-derived compounded sweetener made with neohesperidin dihydrochalcone and gamma cyclodextrin,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:24:59Z,,0,0,09000064b92a80fb
FDA-2026-N-1832-0010,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1299 - 3'-Sialyllactose (3'-SL) Sodium Salt,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:29:24Z,,0,0,09000064b92a8ccf
FDA-2026-N-1832-0006,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1297 - Enzyme-hydrolyzed brown rice protein - Part 1 of 3,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:27:58Z,,0,0,09000064b92a8cca
FDA-2026-N-1832-0012,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1301 - Algal oil (≥45% docosahexaenoic acid from Schizochytrium sp. “JDW-108”),Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:29:36Z,,0,0,09000064b92a8cd4
FDA-2026-N-1832-0002,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1293 - Brazzein preparation produced by Komagataella phaffii “RA-b” expressing a gene encoding for brazzein from Pentadiplandra brazzeana - Part 1 of 2,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:26:49Z,,0,0,09000064b92a8cc5
FDA-2026-N-1832-0004,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1294 - Rebaudioside M produced by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:27:15Z,,0,0,09000064b92a8cc7
FDA-2026-N-1832-0009,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1298 - 2'-fucosyllactose,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:29:07Z,,0,0,09000064b92a8ccd
FDA-2026-N-1832-0013,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1302 - Fermented grape pomace,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:29:44Z,,0,0,09000064b92a8cd5
FDA-2026-N-1832-0001,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1291 - Wattle Seeds (Acacia longifolia),Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:26:31Z,,0,0,09000064b92a8cc4
FDA-2026-N-1832-0011,FDA,FDA-2026-N-1832,GRAS Notice (GRN) 1300 – Zeaxanthin,Notice,General Notice,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T16:29:32Z,,0,0,09000064b92a8cd1
FDA-2022-N-0621-0003,FDA,FDA-2022-N-0621,Advisory Committee; Anesthetic and Analgesic Drug Products Advisory Committee; Renewal,Notice,Renewals,2026-04-27T04:00:00Z,2026,4,,,2026-04-27T17:18:57Z,2026-08125,0,0,09000064b92ad1da
FDA-2026-N-3962-0001,FDA,FDA-2026-N-3962,"Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—
United States (U.S.) 2026–2027 Formula for COVID–19 Vaccine Composition",Notice,Request for Comments,2026-04-27T04:00:00Z,2026,4,2026-04-27T04:00:00Z,2026-05-28T03:59:59Z,2026-05-16T09:00:16Z,2026-08122,1,0,09000064b92ad21d
USDA_FRDOC_0001-3300,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2026-04-27T04:00:00Z,2026,4,2026-04-27T04:00:00Z,,2026-04-27T16:25:44Z,2026-08124,0,0,09000064b92ad21e
EPA-HQ-OW-2000-0006-0001,EPA,EPA-HQ-OW-2000-0006,"Notice of Intent To Develop Ambient Water Quality Criteria for Protection of Human Health - Arsenic, Methylmercury, and Carbofuran; Notice of Data Availability; Request for Data and Information [W-00-19-20-21-I-A-1]",Notice,Notice of Data Availability,2026-04-24T04:00:00Z,2026,4,2026-04-24T04:00:00Z,,2026-04-25T00:32:11Z,00–26222,0,0,09000064b92a970b
EPA-HQ-OW-2000-0005-0001,EPA,EPA-HQ-OW-2000-0005,"Notice of Intent To Develop Ambient Water Quality Criteria for Protection of Human Health - Arsenic, Methylmercury, and Carbofuran; Notice of Data Availability; Request for Data and Information [W-00-19-20-21-I-A-1]",Notice,Notice of Data Availability,2026-04-24T04:00:00Z,2026,4,2026-04-24T04:00:00Z,,2026-04-25T00:22:31Z,00–26222,0,0,09000064b92a970a
EPA-HQ-OW-2000-0004-0001,EPA,EPA-HQ-OW-2000-0004,"Notice of Intent To Develop Ambient Water Quality Criteria for Protection of Human Health - Arsenic, Methylmercury, and Carbofuran; Notice of Data Availability; Request for Data and Information [W-00-19-20-21-I-A-1]",Notice,Notice of Data Availability,2026-04-24T04:00:00Z,2026,4,2026-04-24T04:00:00Z,,2026-04-25T00:17:15Z,00–26222,0,0,09000064b92a9906